295 related articles for article (PubMed ID: 26795450)
21. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
[TBL] [Abstract][Full Text] [Related]
22. Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients.
Nisi M; La Ferla F; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
Br J Oral Maxillofac Surg; 2016 Oct; 54(8):930-935. PubMed ID: 27418080
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Kizub DA; Miao J; Schubert MM; Paterson AHG; Clemons M; Dees EC; Ingle JN; Falkson CI; Barlow WE; Hortobagyi GN; Gralow JR
Support Care Cancer; 2021 May; 29(5):2509-2517. PubMed ID: 32929540
[TBL] [Abstract][Full Text] [Related]
25. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
[TBL] [Abstract][Full Text] [Related]
26. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
27. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.
Madrid C; Bouferrache K; Abarca M; Jaques B; Broome M
Oral Oncol; 2010 Jun; 46(6):468-70. PubMed ID: 20452814
[TBL] [Abstract][Full Text] [Related]
30. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).
Holzinger D; Seemann R; Klug C; Ewers R; Millesi G; Baumann A; Wutzl A
Oral Oncol; 2013 Jan; 49(1):66-70. PubMed ID: 22892237
[TBL] [Abstract][Full Text] [Related]
31. Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Hewson I; Syme D; Bruscino-Raiola F
Aust Dent J; 2012 Jun; 57(2):227-30. PubMed ID: 22624766
[TBL] [Abstract][Full Text] [Related]
32. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S
Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160
[TBL] [Abstract][Full Text] [Related]
33. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
Stanton DC; Balasanian E
J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature.
Katz J; Ordoveza PA
Quintessence Int; 2014 Sep; 45(8):685-90. PubMed ID: 25019116
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Rugani P; Luschin G; Jakse N; Kirnbauer B; Lang U; Acham S
Clin Oral Investig; 2014; 18(2):401-7. PubMed ID: 23749244
[TBL] [Abstract][Full Text] [Related]
36. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
[TBL] [Abstract][Full Text] [Related]
38. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
39. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
Yoshiga D; Sasaguri M; Matsuo K; Kokuryou S; Habu M; Oda M; Kodama M; Tsurushima H; Sakaguchi O; Sakurai T; Tanaka J; Morimoto Y; Yoshioka I; Tominaga K
Osteoporos Int; 2015 Jul; 26(7):1997-2006. PubMed ID: 26037792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
